A new consumer healthcare company – GSK
We are a science-led global healthcare company with a special purpose to improve the quality of human life.
Visit this section
We are a science-led global healthcare company with a special purpose to improve the quality of human life.
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare
Visit this section
When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again.
Be you. Feel good. Keep growing.
Visit this section
Meet some of our employees from various roles, and find out what they really think about working life with us.
Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting
Visit this section
Discover our latest financial performance announcement and search for historical quarterly results materials
Explore the latest news, different ways to stay in touch and available useful resources
Visit this section
Keep up to date with our news and recent announcements
Science can improve health and well-being in so many ways, from the development of everyday healthcare products to medicines and vaccines.
Visit this section
Responsible business is how we do business. Our purpose is to help people to do more, feel better, live longer.
Visit this section
Millions of people live with unmet healthcare needs. We want to help change this, using our scientific expertise, our partnerships and our global reach.
The subsequent websites and web pages are intended for non-UK audiences. Content is provided for the markets’ home audience and may not align with UK regulations.
In 2022, GSK’s Consumer Healthcare business will become an independent company through a proposed demerger from GSK. The new business is expected to be a world-leader in Consumer Health offering the prospect of superior, sustainable sales growth and a highly attractive financial profile for investors.
Led by its purpose to deliver better everyday health with humanity, the Consumer Healthcare business will be strongly positioned to play a vital role in a growing sector that is more relevant than ever. Consumer Healthcare has an exceptional portfolio of world-class, category-leading brands, together with global scale and new innovation capabilities, offering a differentiated proposition that combines trusted science and human understanding.
GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company
GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company
Consumer Healthcare Designate Executive Leadership Team announced
GSK unveils plan for UK headquarters of new Consumer Healthcare
Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company
Brian McNamara, CEO of GSK Consumer Healthcare participated virtually in the 2021 Redburn CEO Conference. He provided an overview of our business and broader industry.
Tobias Hestler, CFO GSK Consumer Healthcare, spoke at the UBS European Conference hosted by analyst Guillaume Delmas.
Tobias Hestler, CFO for GSK Consumer Healthcare participated in the Bernstein Annual Pan European Strategic Decisions Conference.
Brian McNamara, CEO GSK Consumer Healthcare, joined a virtual fireside chat hosted by Barclay’s analyst, Iain Simpson. He provided an overview of the Consumer Healthcare business and our category leading brands.
Brian McNamara, CEO, GSK Consumer Healthcare, presented at the conference and provided an introduction to GSK Consumer Healthcare and outlined our purpose, strategy, category-leading brands and capabilities, as well as an overview of the consumer healthcare sector.
Click here to download slides
Sonya Ghobrial
Head of IR Consumer Healthcare GSK
Email: sonya.x.ghobrial@gsk.com
Global Headquarters (London, UK)
Tim Foley
VP, Global Corporate Media Relations
Madeleine Breckon
Director, Global Corporate Media Relations, Pharmaceuticals
Simon Moore
Director, Global Corporate Media Relations, Vaccines and Global Public Health
Tel: +44 (0)20 8047 5502
Email: corporate.media@gsk.com
USA (Philadelphia)
Kristen Neese
VP, Global Product & Pipeline Communications & US Corporate Communications
Email: kristen.x.neese@gsk.com
Kathleen Quinn
Head, US Corporate Communications
Email: kathleen.x.quinn@gsk.com
Our portfolio of loved and trusted brands includes Sensodyne, parodontax, Polident, Advil, Voltaren, Panadol, Otrivin, Theraflu and Centrum.
We are a leading consumer healthcare company and develop and market some of the world’s best loved brands and products.
This is our global website, intended for visitors seeking information on GSK’s worldwide business. Our market sites can be reached by visiting our market selector.
© 2001-2021 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.
GlaxoSmithKline plc. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
